Z Wan, K Wang, X Yin, X Guo, G Cheng, J Pan - Frontiers in Oncology, 2022 - frontiersin.org
Crizotinib is a tyrosine kinase inhibitor that has been found to be effective in the treatment of
c-ros oncogene 1-positive non-small cell lung cancer. Although this targeted agent for …